Medicus Pharma Ltd.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -14.6% | +817.2% | +237.8% | -27.3% | +75.6% | +47.0% | -28.2% | +622.6% | -75.1% | +4.4% | +81.5% | – | |
| – | +1,022.5% | -31.2% | +104.6% | -39.9% | -39.9% | +193.2% | +46.7% | +9.8% | +3.5% | +13.3% | +11.5% | – | |
| – | +703.0% | -2.1% | +126.8% | -26.3% | -21.1% | +118.1% | +17.4% | +156.4% | -49.5% | -19.6% | +32.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | +879.8% | -89.8% | +8,762.4% | -100.0% | – | – | – | +91.5% | -60.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.